Role of bacteria in experimental colitis (Q34264858)

1 August 2017

1 reference

title

Role of bacteria in experimental colitis (English)

1 reference

1 August 2017

1 reference

Francisco Guarner

1

0 references

author name string

Juan-R Malagelada

series ordinal

2

1 reference

1 August 2017

publication date

1 October 2003

1 reference

Best Practice and Research: Clinical Gastroenterology

1 August 2017

published in

1 reference

1 August 2017

volume

17

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

793-804

1 reference

Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

The effect of infections on susceptibility to autoimmune and allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Inflammatory bowel disease and domestic hygiene in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Military history of patients with inflammatory bowel disease: an epidemiological study among U.S. veterans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Pre-illness dietary factors in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC).

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Childhood infections and the risk of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Familial occurrence of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RBlo T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Mechanisms of acute and chronic intestinal inflammation induced by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Role of intestinal microflora in chronic inflammation and ulceration of the rat colon

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Histochemistry of the surface mucous gel layer of the human colon

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

The hydrophobic barrier properties of gastrointestinal mucus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Modulation of colonic barrier function by the composition of the commensal flora in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Intestinal permeability: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Intestinal permeability and the prediction of relapse in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

1 reference

7 January 2021

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Probiotic therapy fails to improve gut permeability in a hapten model of colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900068-4

7 January 2021

10.1016/S1521-6918(03)00068-4

Identifiers

DOI

1 reference

1 August 2017

1 reference